Immunoprecipitation (IP) assays with anti-TPX2 or anti-Pan-Kla antibodies in HepG2 cells followed by Western blot analysis with antibodies against Pan-Kla or TPX2 confirmed that almost 73% TPX2 was modified by lactylation in HCC cells (Fig 1B and C). Here, KL is linked to hepatocellular carcinoma.